Single-Mitochondrion Sequencing Uncovers Distinct Mutational Patterns and Heteroplasmy Landscape in Mouse Astrocytes

Parnika S Kadam1, Zijian Yang2, Youtao Lu3

  • 1Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Abstract

Insights

Mitochondrial DNA mutations (mt-SNVs) vary across mouse cell types, with neurons showing stronger evolutionary constraints than astrocytes. This research provides foundational data for understanding heteroplasmy and disease thresholds.

Area of Science:

  • Genomics
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Mitochondrial heteroplasmy arises from accumulating mtDNA mutations, disrupting cellular functions.
  • Investigating mitochondrial single-nucleotide variant (mt-SNV) landscapes is crucial for understanding disease.
  • A moderate-throughput method was developed to quantify mt-SNVs in individual mouse cells.

Purpose of the Study:

  • To determine the distribution, proportion, and mutation patterns of mt-SNVs in the mitochondrial genome.
  • To compare mtDNA SNV incidence between mouse neurons and astrocytes.
  • To investigate the cosegregation of variants within mouse mtDNA.

Main Methods:

  • Isolation of 1,645 single mitochondria from individual mouse neurons and astrocytes.
  • Amplification of mt-genomes from isolated mitochondria.
  • Analysis of mt-SNV landscape, mutation patterns, and variant cosegregation.

Main Results:

  • Specific mt-genome sites are permissive to SNVs, while others are under purifying selection.
  • Neurons and astrocytes exhibit different mt-SNV incidence, with specific variants (9027:G>A, 9419:C>T) showing cell-type variation.
  • Neurons display stronger evolutionary constraint (Ka/Ks statistic) compared to astrocytes, with significant linkage between SNV sites (9027 and 9461).

Conclusions:

  • mt-SNV segregation and clonal expansion are locus-specific.
  • This study provides foundational data for understanding heteroplasmy and disease thresholds related to pathogenic variants.